Report cover image

Global Messenger Rna Vaccines And Therapeutics Market Research Report 2025(Status and Outlook)

Publisher Bosson Research
Published Nov 06, 2025
Length 154 Pages
SKU # BOSS20731139

Description

Report Overview

An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.

The global Messenger Rna Vaccines And Therapeutics market size was estimated at USD 13420.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.60% during the forecast period.

This report provides a deep insight into the global Messenger Rna Vaccines And Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Messenger Rna Vaccines And Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Messenger Rna Vaccines And Therapeutics market in any manner.

Global Messenger Rna Vaccines And Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

BioNTech_x000D_

Moderna_x000D_

CureVac_x000D_

Pfizer_x000D_

Glaxo Smith Kline's_x000D_

Daiichi Sankyo Company_x000D_

Intellia Therapeutics_x000D_

Arcturus Therapeutics_x000D_

Emmy Vaccine_x000D_

CSPC_x000D_

CanSino_x000D_

Fosun Pharma

Market Segmentation (by Type)

Self-amplifying_x000D_

Conventional Non-amplifying

Market Segmentation (by Application)

Cancer_x000D_

Infectious Diseases_x000D_

Autoimmune Diseases_x000D_

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Messenger Rna Vaccines And Therapeutics Market

Overview of the regional outlook of the Messenger Rna Vaccines And Therapeutics Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Messenger Rna Vaccines And Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Messenger Rna Vaccines And Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Table of Contents

154 Pages
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Messenger Rna Vaccines And Therapeutics
1.2 Key Market Segments
1.2.1 Messenger Rna Vaccines And Therapeutics Segment by Type
1.2.2 Messenger Rna Vaccines And Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Messenger Rna Vaccines And Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Messenger Rna Vaccines And Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Messenger Rna Vaccines And Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Messenger Rna Vaccines And Therapeutics Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Messenger Rna Vaccines And Therapeutics Product Life Cycle
3.3 Global Messenger Rna Vaccines And Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Messenger Rna Vaccines And Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Messenger Rna Vaccines And Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Messenger Rna Vaccines And Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Messenger Rna Vaccines And Therapeutics Market Competitive Situation and Trends
3.8.1 Messenger Rna Vaccines And Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Messenger Rna Vaccines And Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Messenger Rna Vaccines And Therapeutics Industry Chain Analysis
4.1 Messenger Rna Vaccines And Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Messenger Rna Vaccines And Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Messenger Rna Vaccines And Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Messenger Rna Vaccines And Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 Messenger Rna Vaccines And Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Messenger Rna Vaccines And Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Messenger Rna Vaccines And Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Messenger Rna Vaccines And Therapeutics Price by Type (2020-2025)
7 Messenger Rna Vaccines And Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Messenger Rna Vaccines And Therapeutics Market Sales by Application (2020-2025)
7.3 Global Messenger Rna Vaccines And Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Messenger Rna Vaccines And Therapeutics Sales Growth Rate by Application (2020-2025)
8 Messenger Rna Vaccines And Therapeutics Market Sales by Region
8.1 Global Messenger Rna Vaccines And Therapeutics Sales by Region
8.1.1 Global Messenger Rna Vaccines And Therapeutics Sales by Region
8.1.2 Global Messenger Rna Vaccines And Therapeutics Sales Market Share by Region
8.2 Global Messenger Rna Vaccines And Therapeutics Market Size by Region
8.2.1 Global Messenger Rna Vaccines And Therapeutics Market Size by Region
8.2.2 Global Messenger Rna Vaccines And Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Messenger Rna Vaccines And Therapeutics Sales by Country
8.3.2 North America Messenger Rna Vaccines And Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Messenger Rna Vaccines And Therapeutics Sales by Country
8.4.2 Europe Messenger Rna Vaccines And Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Messenger Rna Vaccines And Therapeutics Sales by Region
8.5.2 Asia Pacific Messenger Rna Vaccines And Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Messenger Rna Vaccines And Therapeutics Sales by Country
8.6.2 South America Messenger Rna Vaccines And Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Messenger Rna Vaccines And Therapeutics Sales by Region
8.7.2 Middle East and Africa Messenger Rna Vaccines And Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Messenger Rna Vaccines And Therapeutics Market Production by Region
9.1 Global Production of Messenger Rna Vaccines And Therapeutics by Region(2020-2025)
9.2 Global Messenger Rna Vaccines And Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Messenger Rna Vaccines And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Messenger Rna Vaccines And Therapeutics Production
9.4.1 North America Messenger Rna Vaccines And Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Messenger Rna Vaccines And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Messenger Rna Vaccines And Therapeutics Production
9.5.1 Europe Messenger Rna Vaccines And Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Messenger Rna Vaccines And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Messenger Rna Vaccines And Therapeutics Production (2020-2025)
9.6.1 Japan Messenger Rna Vaccines And Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Messenger Rna Vaccines And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Messenger Rna Vaccines And Therapeutics Production (2020-2025)
9.7.1 China Messenger Rna Vaccines And Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Messenger Rna Vaccines And Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 BioNTech_x000D_
10.1.1 BioNTech_x000D_ Basic Information
10.1.2 BioNTech_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.1.3 BioNTech_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.1.4 BioNTech_x000D_ Business Overview
10.1.5 BioNTech_x000D_ SWOT Analysis
10.1.6 BioNTech_x000D_ Recent Developments
10.2 Moderna_x000D_
10.2.1 Moderna_x000D_ Basic Information
10.2.2 Moderna_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.2.3 Moderna_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.2.4 Moderna_x000D_ Business Overview
10.2.5 Moderna_x000D_ SWOT Analysis
10.2.6 Moderna_x000D_ Recent Developments
10.3 CureVac_x000D_
10.3.1 CureVac_x000D_ Basic Information
10.3.2 CureVac_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.3.3 CureVac_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.3.4 CureVac_x000D_ Business Overview
10.3.5 CureVac_x000D_ SWOT Analysis
10.3.6 CureVac_x000D_ Recent Developments
10.4 Pfizer_x000D_
10.4.1 Pfizer_x000D_ Basic Information
10.4.2 Pfizer_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.4.3 Pfizer_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.4.4 Pfizer_x000D_ Business Overview
10.4.5 Pfizer_x000D_ Recent Developments
10.5 Glaxo Smith Kline's_x000D_
10.5.1 Glaxo Smith Kline's_x000D_ Basic Information
10.5.2 Glaxo Smith Kline's_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.5.3 Glaxo Smith Kline's_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.5.4 Glaxo Smith Kline's_x000D_ Business Overview
10.5.5 Glaxo Smith Kline's_x000D_ Recent Developments
10.6 Daiichi Sankyo Company_x000D_
10.6.1 Daiichi Sankyo Company_x000D_ Basic Information
10.6.2 Daiichi Sankyo Company_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.6.3 Daiichi Sankyo Company_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.6.4 Daiichi Sankyo Company_x000D_ Business Overview
10.6.5 Daiichi Sankyo Company_x000D_ Recent Developments
10.7 Intellia Therapeutics_x000D_
10.7.1 Intellia Therapeutics_x000D_ Basic Information
10.7.2 Intellia Therapeutics_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.7.3 Intellia Therapeutics_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.7.4 Intellia Therapeutics_x000D_ Business Overview
10.7.5 Intellia Therapeutics_x000D_ Recent Developments
10.8 Arcturus Therapeutics_x000D_
10.8.1 Arcturus Therapeutics_x000D_ Basic Information
10.8.2 Arcturus Therapeutics_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.8.3 Arcturus Therapeutics_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.8.4 Arcturus Therapeutics_x000D_ Business Overview
10.8.5 Arcturus Therapeutics_x000D_ Recent Developments
10.9 Emmy Vaccine_x000D_
10.9.1 Emmy Vaccine_x000D_ Basic Information
10.9.2 Emmy Vaccine_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.9.3 Emmy Vaccine_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.9.4 Emmy Vaccine_x000D_ Business Overview
10.9.5 Emmy Vaccine_x000D_ Recent Developments
10.10 CSPC_x000D_
10.10.1 CSPC_x000D_ Basic Information
10.10.2 CSPC_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.10.3 CSPC_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.10.4 CSPC_x000D_ Business Overview
10.10.5 CSPC_x000D_ Recent Developments
10.11 CanSino_x000D_
10.11.1 CanSino_x000D_ Basic Information
10.11.2 CanSino_x000D_ Messenger Rna Vaccines And Therapeutics Product Overview
10.11.3 CanSino_x000D_ Messenger Rna Vaccines And Therapeutics Product Market Performance
10.11.4 CanSino_x000D_ Business Overview
10.11.5 CanSino_x000D_ Recent Developments
10.12 Fosun Pharma
10.12.1 Fosun Pharma Basic Information
10.12.2 Fosun Pharma Messenger Rna Vaccines And Therapeutics Product Overview
10.12.3 Fosun Pharma Messenger Rna Vaccines And Therapeutics Product Market Performance
10.12.4 Fosun Pharma Business Overview
10.12.5 Fosun Pharma Recent Developments
11 Messenger Rna Vaccines And Therapeutics Market Forecast by Region
11.1 Global Messenger Rna Vaccines And Therapeutics Market Size Forecast
11.2 Global Messenger Rna Vaccines And Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Messenger Rna Vaccines And Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Messenger Rna Vaccines And Therapeutics Market Size Forecast by Region
11.2.4 South America Messenger Rna Vaccines And Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Messenger Rna Vaccines And Therapeutics by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Messenger Rna Vaccines And Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Messenger Rna Vaccines And Therapeutics by Type (2026-2033)
12.1.2 Global Messenger Rna Vaccines And Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Messenger Rna Vaccines And Therapeutics by Type (2026-2033)
12.2 Global Messenger Rna Vaccines And Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Messenger Rna Vaccines And Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Messenger Rna Vaccines And Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.